Fingerprint
Dive into the research topics of 'Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
Gerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R. Foster, Erik J. Asmus, Andrea Wahner Hendrickson, Aminah Jatoi, Matthew S. Block, Carrie L. Langstraat, Gretchen E. Glaser, Tri A. Dinh, Matthew W. Robertson, John K. Camoriano, Kristina A. Butler, John A. Copland, S. John Weroha
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations